PSG’s PBM Customer Satisfaction Report provides the most in-depth picture of the PBM landscape today, leveraging perspectives taken directly from employer and health plan…
Leverage Integrated Data to Inform Better Benefit Decisions An estimated 22 million U.S. adults are affected by a chronic liver condition called metabolic dysfunction-associated…
Will This Gene Therapy Break Payers’ Budgets? Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a severe, inherited skin disorder that has no cure, and until…
New Research Reveals Strategic Approaches to Balancing Member Access and Affordability with Pharmacy Spend Control DALLAS, TX – June 10, 2025 – Pharmaceutical Strategies…
Join us for an in-depth exploration of one of the most impactful developments in prescription drug benefits: GLP-1 medications for type 2 diabetes and…
Maximizing Value through Medical Drug Rebate Strategies PSG’s 2025 Trends in Specialty Drug Benefits Report, released in late April, revealed several unexpected and…
Understand Important Components of a Modular PBA Strategy for Employers In 2023, Blue Shield of California (BSC) announced a new pharmacy supply chain…
